MSB 4.69% $1.45 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-442

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 524 Posts.
    lightbulb Created with Sketch. 1511
    Youngandnaive .. saw your post on disallowed.. well done.

    Some of the posters there have Zero idea.

    For years now , the Prof has been taking about manufacturing. Have another read of today’s Twst.
    Its safe and will tick FDA rigorous scrutiny.

    Exteact:
    ... ”Moreover, we have proprietary technologies developed using serum-free media and the use

    of bioreactors as it allows to scale up to much higher levels - as and when commercial requirements arises - so that we are not in anyway constrained by manufacturing” ....

    End of extract.

    Youngandnaive - the only other comment I have is if you know enough about the Prof (his personality & integrity) , listen to the words he says .. he doesn’t make them lightly.

    Hence my interpretation. .. there is a hidden message
    in today’s transcript .

    Vinny - i tried posting on disallowed but due to IT shortcomings, was not able to.

    If you are able to ... let them know the Spartans are coming !

    Best,
    Anjo !
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.